Science and Development Network
News, views and information about science, technology and the developing world
Source: Nature
1 June 2006 | EN
Costa Rican orchid: researchers hope the nation's biodiversity will yield new drugs
IRD / Anthony
Researchers at Costa Rica’s flagship biodiversity institute are hoping that an ambitious new project will ease its financial worries.
The National Biodiversity Institute's (INBio) five-year project aims to find chemicals in wild species that could form the basis of new drugs, reports Rex Dalton in Nature.
INBio’s previous efforts at 'bioprospecting' failed to yield major moneymaking products, and the institute hit financial problems when several grants ended in 2005 (see Funding crisis hits Costa Rican biodiversity institute).
This time around INBio is looking for compounds that can be easily isolated and duplicated from sources such as fungi, leaves or bacteria, instead of focusing on insects as it did previously.
The findings will eventually be entered into a free access database for researchers around the world to investigate. Profits from successful findings will be ploughed back into INBio in the form of licence fees.
Trade and climate policy must be linked post-2012 to ensure a low-carbon future
Rapid diagnostic tests may present a quick and easy-to-use solution for improved malaria diagnosis
Add your comment
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.